PRR could reverse the abnormal changes of Cpt1a, Acat2, Ehhadh, and Hadha (Figure 5A), among which Cpt1a, Ehhadh, and Hadha are fatty acid β-oxidation genes, indicating that fatty acid β-oxidation might play important role in the treatment of cholestasis by PRR. Here, CPT1A is linked to cholestasis.